Cosmetic composition comprising bentonite as active ingredient
A technology of cosmetic composition and active ingredients, applied in the direction of cosmetics, cosmetic preparations, dressing preparations, etc., can solve the problems of no bentonite improvement or treatment of atopic dermatitis, no treatment effect of atopic dermatitis, etc., to reduce Redness, skin brightening, expression reducing effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment approach
[0046] In the following description, only the parts necessary for understanding the embodiments of the present invention will be described, and it should be noted that descriptions of other parts will be omitted within the scope not to obscure the gist of the present invention.
[0047] The terms or words used in this specification and the scope of protection of the invention described below should not be limitedly interpreted with conventional or dictionary meanings, but should be based on the inventor's ability to explain in the best way The principle of properly defining the concepts of terms based on their own inventions should be interpreted with meanings and concepts consistent with the technical ideas of the present invention. Therefore, the embodiments described in this specification and the structure shown in the drawings are only the most preferred embodiment of the present invention, and do not represent all technical ideas of the present invention. Therefore, it sho...
Embodiment 1
[0078] Embodiment 1: prepare bentonite sample
[0079] In order to measure the anti-inflammatory effect of bentonite and the improvement effect of atopic dermatitis, the dry powder of bentonite produced in Korea produced in Yangnam-myeon, Gyeongju, Korea was dissolved in 0.5% dimethyl sulfoxide (DMSO), and then the culture medium Or 3 times diluted with distilled water for experiments.
[0080] As described in Table 1 below, the bentonite whose interlayer ions were replaced by calcium ions was separated into bentonites with particle sizes below 50 μm, 10 μm to 25 μm, and 0.1 μm to 0.5 μm as Examples 1 to 3, and the interlayer ions were replaced by magnesium ions The bentonite was separated into bentonite with a particle size of 50 μm or less, 10 μm to 25 μm, and 0.1 μm to 0.5 μm as Examples 4 to 6, and experiments were carried out.
[0081] Table 1
[0082] serial number Sample name element granularity Example 1 Bgp40b-p-Ca.S Calcium bentonite ...
Embodiment 2
[0083] Example 2: Preparing Cells
[0084] In order to evaluate the cytotoxicity of bentonite and confirm the anti-inflammatory effect and atopic dermatitis inhibitory effect, HaCaT cell line, which is human-derived skin keratinocytes, and HS68 cells, which are human foreskin-derived fibroblasts, were prepared strain.
[0085] Human keratinocytes (HaCaT) were purchased from Korean Cell Line Bank (Korean Cell Line Bank; Seoul, Korea) and used, and dermal cells (HS68) were purchased from American Type Culture Collection (ATCC, American Type Culture Collection, deposit number: 1635) , and use the .
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More